All Mergers and acquisitions articles – Page 6

Business
EU scrutinises Syngenta–ChemChina union

2016-11-01T13:25:00Z

European commission investigates competition concerns in agricultural megamerger
Business
AstraZeneca sheds multiple drugs

2016-10-25T17:30:00Z

Spate of licensing deals for non-core products as firm further tightens R&D focus
Business
India’s Intas bags UK and Irish generics

2016-10-11T15:43:00Z

Teva sheds former Actavis business to satisfy competition requirements of its Allergan generics takeover
Business
Pfizer to sell Hospira Infusion Systems to ICU Medical

2016-10-10T16:16:00Z

$1bn deal brings together medical device units, as Pfizer focuses on Hospira’s biosimilars and generics
Business
Lilly to buy Boehringer’s pet vaccines

2016-10-10T10:27:00Z

Deal strengthens Lilly’s animal medicine division following recent acquisition
Business
Lanxess to buy Chemtura for additives

2016-10-03T10:12:00Z

€2.4 billion deal brings lubricant additives and flame retardants expertise and expands North American operations
Business
Pfizer scraps plans to split

2016-09-30T15:43:00Z

Previously separated ‘innovative’ and ‘value’ business segments will remain autonomous under Pfizer umbrella
Business
US senators examine agrochem consolidation

2016-09-27T15:02:00Z

Judiciary committee voices concern over pending merger deals
Business
Acquisition spree moves Allergan towards innovative drugs

2016-09-26T15:06:00Z

Company acquires five companies in six weeks across three disease areas
Business
J&J to buy Abbott Medical Optics

2016-09-22T12:34:00Z

Deal adds laser surgery and cataract lens replacements to J&J’s eyecare business
Business
Danaher boosts diagnostics with Cepheid buyout

2016-09-22T10:24:00Z

$4bn deal strengthens Danaher’s life sciences portfolio
Business
Fertiliser firms Agrium and PotashCorp to merge

2016-09-20T16:18:00Z

Canadian combination will create one of the largest crop nutrient companies in the world.
Business
Bayer to buy seed giant Monsanto

2016-09-20T15:09:00Z

$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
Opinion
Bend or break

2016-09-02T12:00:00Z

To succeed over generations, companies need both flexibility and strength
Business
Pfizer to buy Astrazeneca’s antibiotics

2016-08-25T11:38:00Z

Deal tops up Pfizer’s late-stage development pipeline, but AZ will retain biological programmes
Business
Pfizer gambles on $14bn Medivation deal

2016-08-24T13:06:00Z

Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
Business
EU examines Dow–DuPont union

2016-08-22T14:07:00Z

European commission probes competition implications of the planned mega-merger
Business
US government sued over merger crackdown

2016-08-11T16:53:00Z

Business groups challenge Obama’s steps to limit tax inversions
Business
Amgen and Advaxis partner on immuno-oncology

2016-08-04T00:00:00Z

Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
Business
Arkema boosts Bostik adhesives

2016-07-26T13:00:00Z

New adhesives plant in Sweden and acquisition of Dutch firm Den Braven